胰高血糖素样肽1水平预测急性心肌梗死患者心血管风险
在918例心肌梗死患者中评估入院时总GLP-1对心血管结局的预测能力,发现GLP-1与心血管死亡、非致死性心肌梗死或非致死性卒中的复合终点独立相关,且对30天内早期事件预测优于其他生物标志物。
要点
- 急性心肌梗死患者入院时GLP-1水平与心血管不良事件独立相关。
- GLP-1对30天内早期事件的预测能力优于hs-Troponin T、GFR、hs-CRP和NT-proBNP。
- 在NSTEMI患者中,将GLP-1加入GRACE风险评分可提高随时间变化的AUC。
核心结论
- 因心肌梗死住院的患者中,GLP-1水平与心血管事件相关。
研究设计与样本
- 研究纳入918例心肌梗死患者,其中321例ST段抬高型心肌梗死和597例非ST段抬高型心肌梗死(NSTEMI),于入院时检测总GLP-1、NT-proBNP水平并计算GRACE评分。
主要发现
- Kaplan-Meier生存曲线和单变量Cox回归分析显示GLP-1与不良结局相关,对数化GLP-1值的风险比(HR)为6.29(95%CI 2.67-14.81;P<0.0001)。
- 进一步调整年龄、性别、心血管病家族史、吸烟、糖尿病、高血压、高胆固醇血症、GFR CKD-EPI、hs-CRP、hs-Troponin T和NT-proBNP后,HR仍显著为10.98(95%CI 2.63-45.90;P=0.0010)。
- 时间依赖ROC曲线分析表明GLP-1是早期事件的强指标,对入院后30天内事件预测优于hs-Troponin T、GFR CKD-EPI、hs-CRP和NT-proBNP。
- 在NSTEMI患者中,将GLP-1加入GRACE风险估计可提高随时间变化的ROC曲线下面积。
临床怎么用
- 对于急性心肌梗死患者,入院时检测GLP-1水平可能有助于早期风险分层,尤其在NSTEMI患者中可补充GRACE评分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Glucagon-like peptide 1 (GLP-1) is a gut incretin hormone inducing post-prandial insulin secretion. Glucagon-like peptide 1 levels were recently found to be increased in patients with acute myocardial infarction. Glucagon-like peptide 1 receptor agonists improve cardiovascular outcomes in patients with diabetes. The aim of this study was to assess the predictive capacity of GLP-1 serum levels for cardiovascular outcome in patients with myocardial infarction. METHODS AND RESULTS: In 918 patients presenting with myocardial infarction [321 ST-segment elevation myocardial infarction and 597 non-ST-segment elevation myocardial infarction (NSTEMI)] total GLP-1, N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels and the Global Registry of Acute Coronary Events (GRACE) score were assessed at time of hospital admission. The primary composite outcome of the study was the first occurrence of cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke. Kaplan-Meier survival plots and univariable Cox regression analyses found GLP-1 to be associated with adverse outcome [hazard ratio (HR) of logarithmized GLP-1 values: 6.29, 95% confidence interval (CI): 2.67-14.81; P < 0.0001]. After further adjustment for age, sex, family history of cardiovascular disease, smoking, diabetes, hypertension, hypercholesterinaemia, glomerular filtration rate (GFR) CKD-EPI, hs-CRP, hs-Troponin T, and NT-proBNP levels the HR remained significant at 10.98 (95% CI: 2.63-45.90; P = 0.0010). Time-dependent receiver operating characteristic curve analyses illustrated that GLP-1 levels are a strong indicator for early events. For events up to 30 days after admission, GLP-1 proved to be superior to other biomarkers including hs-Troponin T, GFR CKD-EPI, hs-CRP, and NT-proBNP. Adjustment of the GRACE risk estimate by addition of GLP-1 increased the area under the receiver operating characteristic curve over time in NSTEMI patients. CONCLUSION: In patients hospitalized for myocardial infarction, GLP-1 levels are associated with cardiovascular events.
引用
- Kahles F, Rückbeil MV, Mertens RW, et al. Glucagon-like peptide 1 levels predict cardiovascular risk in patients with acute myocardial infarction. Eur Heart J. 2020. PMID: 31620788. doi:10.1093/eurheartj/ehz728
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。